View
218
Download
1
Embed Size (px)
DESCRIPTION
Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.
Citation preview
-=6 HEADLINES
Indian Market
Indian equity markets were up 0.43%
Nifty up by 25.75 pts and settle at 6069.30
Sensex up by 101.23 pts at 19990.18
Bank Nifty up by 11.50 pts at 12643.00
Global Market
European markets were up with FTSE up by 13.34 closed at 6570 ,CAC up by 25.83 closed at 3947 and DAX up 48.52 closed at 8230
Dow future was DOWN by 5 closed at
14978.00
WWW.EPICRESEARCH.CO 09752199966
DAILY EQUITY NEWSLETTER
9TH MAY 2013
HEADLINES
• See room for only one more rate cut by
RBI: JPMorgan
• 33% Indians feel offering cash to win biz
is justified: E&Y
• Diageo gets around 4% stake in USL via
open offer: Sources
• Global economic growth slowed in April:
PMIs
FII’s and DII’s
CATEGORY DATE BUY SELL NET
FII 7-May-13 3021.82 2366.61 655.2
DII 7-May-13 744.18 1473.35 -729.17
NIFTY DAILY PIVOTS
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 6229 6161 6093 6068 6025 6000 5957 5889 5821
WWW.EPICRESEARCH.CO 09752199966
MARKET ANALYSIS:
Gains in European and Asian stocks pushed key benchmark indices to intraday high in late trade. The
barometer index, the S&P BSE Sensex, hit 14-week high above the psychological 20,000 mark. The
CNX Nifty hit over 14-week high. The Sensex was provisionally up 136.10 points or 0.68%, up 173.83
points from the day's low and off 12.22 points from the day's high. Index heavyweight and cigarette
major ITC advanced to hit record high on reports the Uttar Pradesh state government on Tuesday, 7
May 2013, slashed VAT on cigarette/cigar from existing 50% to 25%.
Index heavyweight Reliance Industries (RIL) was slightly higher after seeing intraday volatility.
Ranbaxy Laboratories declined after weak Q1 result. Lupin advanced to scale a record high after
reporting strong Q4 results. HDFC surged to record high after declaring good Q4 result. The market
breadth, indicating the overall health of the market, was positive
Key benchmark indices edged higher amid initial volatility. The market retained positive zone in
morning trade. The barometer index, the S&P BSE Sensex, hit its highest level in almost 14 weeks.
The CNX Nifty hit 14-week high. Key benchmark indices pared gains in mid-morning trade. The
Sensex cut losses after sliding to intraday low in early afternoon trade. The Sensex regained strength in
afternoon trade. The market retained positive zone in mid-afternoon trade. The Sensex moved past the
psychological 20,000 level in late trade.
The market breadth, indicating the overall health of the market, was positive. On BSE, 975 shares rose
and 974 shares fell. A total of 84 shares were unchanged.
STOCKS TO WATCH
BAJAJ AUTO
CAIRN INDIA
TCS
INFOSYS
SCRIPS IN BAN PERIOD
WWW.EPICRESEARCH.CO 09752199966
.
EXPERT OPINION
NIFTY
Nifty looks Bearish
Strategy: Sell on rise
Support: 6020
Resistance: 6100
BANK NIFTY
Bank Nifty looks Bearish
Strategy: Sell on rise
Support: 12580
Resistance: 12700
460
.0
GAINERS AND LOOSERS
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
CASH APOLLO TYRE B TGT HIT
CASH HDIL B TGT HIT
FUTURE CENTURY TEXTILE
B NOT
EXECUTED
FUTURE BHARTI AIRTEL
B SL TRIGERRED
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHANG
E
HDFC 885.00 3070.55 853.75 31.25 3.66
Ultratec 1978.20 972.55 1928.55 49.65 2.57
Lupin 730.80 3109.64 714.60 16.20 2.27
ITC 342.80 4755.34 335.30 7.50 2.24
Power Grid
114.75 2600.52 112.70 2.05 1.82
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHAN
GE
Ranbaxy Labs
443.85 2155.49 457.3 -13.45 -2.94
Bharti Airtel
324.2 3653.09 331.2 -7 -2.11
Tata Steel
318.65 5171.89 324.7 -6.05 -1.86
Bank Of Baroda
692.1 743.7 704.9 -12.8 -1.82
Hero Moto
1676.35 262.63 1706.35 -30 -1.76
6
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
DISH TV BUY 69.10 69.60 70.10 68.60
PVR BUY 350.00 351.00 352.00 349.00
FUTURE
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
HINDALCO BUY 103.50 104.00 104.50 103.00
INDUS IND BUY 493.50 495.50 497.50 491.50
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.